Adult RSV and Pneumococcal Vaccines: Who Should Get Them?

Table of Contents

Medical disclaimer

This article is general educational information, not medical advice, diagnosis, or treatment. Vaccine decisions can depend on your age, past vaccine records, medical conditions, allergies, immune system, pregnancy status, and local availability. Use this article to prepare questions, not to decide on your own whether to start, delay, repeat, or skip a vaccine. Information current as of June 18, 2026.

Should you check RSV or pneumococcal vaccine eligibility now?

If you are 50 or older, or you are a younger adult with certain medical risks, it is reasonable to check your adult vaccine record now. RSV and pneumococcal disease are different infections.

RSV is a respiratory virus. Pneumococcal disease is caused by bacteria that can lead to pneumonia, bloodstream infection, or meningitis.

The two vaccine decisions often come up together because both illnesses can be more serious in older adults and in people with lung disease, heart disease, immune system problems, and other chronic conditions. The timing is not identical.

RSV vaccine is usually most useful before RSV season, often late summer to early fall in much of the continental United States. Pneumococcal vaccination is more record-based: whether you need it depends heavily on your age, risk factors, and which pneumococcal vaccines you have already received.

What to check now

Bring a vaccine record if you have one. A pharmacy printout, state immunization record, patient portal list, or old clinic record can help prevent unnecessary repeat doses. Check these points before your appointment:

Your age, especially whether you are 50 or older, 65 or older, or 75 or older.
Whether you have had any RSV vaccine before.
Whether you have ever received PCV13, PCV15, PCV20, PCV21, or PPSV23.
Any severe allergic reaction after a past vaccine.
Current moderate or severe illness, which may lead a clinician to delay vaccination.
Heart disease, lung disease, end-stage renal disease or dependence on hemodialysis or other renal replacement therapy, diabetes complicated by chronic kidney disease, neuropathy, retinopathy, or similar end-organ damage, immune compromise, severe obesity, chronic liver disease, or residence in a nursing home.
Whether you are getting flu, COVID-19, shingles, or other vaccines at the same visit.

For pneumococcal vaccines, the product name and date decide the next step. Bring the record so the vaccine provider can match it to the current CDC schedule.

If you are pregnant or planning care for a newborn, use the pregnancy and infant RSV guidance instead of the adult-only shortcut. CDC describes a separate maternal RSV vaccine option: Pfizer Abrysvo during weeks 32 through 36 of pregnancy, usually September through January in most of the United States.

This is an alternative to infant immunization with nirsevimab or clesrovimab; most infants will not need both. Pfizer’s Abrysvo is the only RSV vaccine approved and recommended for use during pregnancy; CDC says Arexvy and mResvia are not approved for use during pregnancy.

Who is in the adult RSV vaccine group?

Image generation prompt:

Visual only. Topic context: 성인 RSV·폐렴구균 백신, 지금 맞아야 할 사람은 누구인가. Section context: Who is in the adult RSV vaccine group?. Reader moment: CDC recommends one dose of RSV vaccine for all adults ages 75 and older. CDC also recommends one dose for adults ages 50 through 74 who are at increased risk of severe RSV illness. Scene direction: a calm but urgent home-based healthcare scene showing an adult deciding to seek medical help after concerning muscle discomfort; only partial body visible, one hand supporting a sore arm or shoulder while the other reaches for a phone; natural light, serious but not dramatic. Create a realistic editorial healthcare image for a U.S. medication information blog. Show a patient-education or help-seeking moment, not a product shot and not a generic checklist workspace. Use unbranded home, clinic, pharmacy, or telehealth context as appropriate. Safety constraints: no identifiable real drug, pill, capsule, injection pen, bottle, carton, NDC label, logo, brand mark, manufacturer packaging, prescription label, patient name, barcode, readable dosage instruction, or readable screen/text. Do not imply diagnosis, treatment, or that the viewer should take any medicine. No dramatic emergency imagery, no staged smiling stock-photo feel. CRITICAL: no text, words, letters, or numbers in the image. Calm medical color palette, natural lighting, professional healthcare editorial style. Style: US medication safety editorial: unbranded clinical photography or clean patient education visual; no cartoon characters, no fake pill identification, no branded packaging. 16:9 aspect ratio.

Generate the image, replace this block, then delete this prompt before publishing.

CDC recommends one dose of RSV vaccine for all adults ages 75 and older. CDC also recommends one dose for adults ages 50 through 74 who are at increased risk of severe RSV illness.

Risk factors include chronic heart disease, chronic lung or breathing disease, end-stage renal disease or dependence on hemodialysis or other renal replacement therapy, diabetes complicated by chronic kidney disease, neuropathy, retinopathy, or similar end-organ damage, or requiring insulin or SGLT2 inhibitor treatment, certain neurologic or neuromuscular conditions that make airway clearance harder or cause respiratory muscle weakness, chronic liver disease, chronic blood disorders, severe obesity, moderate or severe immune compromise, and living in a nursing home.

Note: isolated hypertension alone is not included in CDC’s cardiovascular risk list. Clinicians may also consider other situations that raise the risk of severe viral respiratory disease, such as frailty or difficulty accessing higher-level medical care in remote areas.

RSV vaccine is not currently an annual vaccine. People who already received one adult RSV vaccine dose are considered to have completed RSV vaccination for now, unless future recommendations change.

Eligible adults may receive RSV vaccine at any time of year, but CDC describes late summer and early fall as the best time for many adults because it comes before RSV usually spreads widely. In much of the continental United States, that often means August through October.

Who is in the adult pneumococcal vaccine group?

CDC recommends pneumococcal vaccination for all adults 50 years or older who have never received a pneumococcal conjugate vaccine or whose previous pneumococcal vaccine history is unknown. The main adult pneumococcal conjugate vaccine options listed by CDC are PCV15, PCV20, and PCV21.

If PCV20 or PCV21 is used, CDC says no PPSV23 dose is indicated afterward for that series. If PCV15 is used, CDC recommends PPSV23 one year later for most adults.

A shorter minimum interval may be considered in adults with an immunocompromising condition, a cochlear implant, or a cerebrospinal fluid leak. Some adults younger than 50 may also need pneumococcal vaccination because of medical conditions or other risk factors.

That group is more complicated because age, diagnosis, and vaccine history all matter. Adults 65 or older who previously received PCV13 at any age, but not PCV15, PCV20, or PCV21, and PPSV23 at or after age 65 may have the option, through shared clinical decision-making, to receive PCV20 or PCV21 or to receive no additional pneumococcal vaccine.

Shared clinical decision-making means the choice is made after reviewing personal risk and past vaccination, rather than by a single automatic rule.

How RSV and pneumococcal vaccine decisions differ

Here is a quick comparison for everyday planning.

Question	RSV vaccine	Pneumococcal vaccine
What does it target?	Respiratory syncytial virus, a virus that can cause serious lower breathing illness	Pneumococcal bacteria, which can cause pneumonia, meningitis, and bloodstream infection
Main adult age group	All adults 75 and older; adults 50 through 74 with increased risk	All adults 50 and older if never vaccinated with PCV or history is unknown; younger adults with certain risks
Usual dose idea	One adult dose for eligible adults; people who already received an adult RSV dose usually do not need another dose now	Depends on product and history; PCV20 or PCV21 may complete vaccination, while PCV15 usually needs PPSV23 later
Best timing	Often late summer to early fall before RSV season	Any appropriate visit once eligibility and records are reviewed

These vaccines do not replace each other. A person may be eligible for one, both, or neither at a given visit.

Side effects and warning signs to know

Most expected vaccine reactions are short-term and local. RSV vaccine can cause pain, redness, or swelling where the shot is given. Tiredness, fever, headache, queasiness, diarrhea, and muscle or joint pain may also happen.

Pneumococcal conjugate vaccines can cause redness, swelling, pain, tenderness, fever, tiredness, headache, muscle aches, joint pain, chills, or appetite changes. PPSV23 can cause similar shot-site symptoms, tiredness, headache, fever, chills, or muscle aches.

Serious allergic reactions are rare but need emergency care. Warning signs include hives, swelling of the face or throat, trouble breathing, a fast heartbeat, dizziness, or weakness after vaccination.

For RSV vaccines, keep two source statements separate. FDA required Guillain-Barre syndrome (GBS) warnings in the prescribing information for Abrysvo and Arexvy after reviewing clinical trials, VAERS reports, and a postmarketing observational study.

FDA said the evidence suggests increased risk, but is insufficient to establish a causal relationship. That postmarketing Medicare study evaluated beneficiaries 65 years and older.

CDC vaccine information uses broader patient-facing wording that an increased GBS risk after RSV vaccination in adults 60 and older cannot currently be confirmed or ruled out.

Fainting can happen after medical procedures, including vaccination. If you tend to faint with shots, mention that before vaccination so the staff can help you sit or lie down safely.

Can these vaccines be given with other shots?

CDC says RSV vaccines can be given during the same visit as other adult vaccines. The same-visit decision can depend on which vaccines you are due for, how likely you are to return for another visit, your risk of disease, and how you usually react to vaccines.

For RSV vaccine, CDC notes that data on giving it with other respiratory virus vaccines are limited. Antibody levels may be lower when RSV vaccine is given with certain other respiratory vaccines, but the clinical meaning is not known.

Same-day vaccination may also increase common side effects such as fever, headache, muscle aches, or injection-site pain. Pneumococcal vaccine planning is less about season and more about past products.

If your record is unclear, the vaccine provider may use CDC timing tools or clinical guidance to decide which product fits your history.

Which vaccine names might you hear?

Image generation prompt:

Visual only. Topic context: 성인 RSV·폐렴구균 백신, 지금 맞아야 할 사람은 누구인가. Section context: Which vaccine names might you hear?. Reader moment: For adult RSV vaccination, separate the CDC recommendation from each product's FDA indication. CDC recommends RSV vaccination for all adults ages 75 and older and for adults ages 5. Scene direction: a two-step response scene: foreground shows a person at home noticing muscle weakness or feeling unwell, background softly suggests a clinic call or telehealth connection on a blank screen; the mood is calm, immediate, and practical. Create a realistic editorial healthcare image for a U.S. medication information blog. Show a patient-education or help-seeking moment, not a product shot and not a generic checklist workspace. Use unbranded home, clinic, pharmacy, or telehealth context as appropriate. Safety constraints: no identifiable real drug, pill, capsule, injection pen, bottle, carton, NDC label, logo, brand mark, manufacturer packaging, prescription label, patient name, barcode, readable dosage instruction, or readable screen/text. Do not imply diagnosis, treatment, or that the viewer should take any medicine. No dramatic emergency imagery, no staged smiling stock-photo feel. CRITICAL: no text, words, letters, or numbers in the image. Calm medical color palette, natural lighting, professional healthcare editorial style. Style: US medication safety editorial: unbranded clinical photography or clean patient education visual; no cartoon characters, no fake pill identification, no branded packaging. 16:9 aspect ratio.

Generate the image, replace this block, then delete this prompt before publishing.

For adult RSV vaccination, separate the CDC recommendation from each product’s FDA indication. CDC recommends RSV vaccination for all adults ages 75 and older and for adults ages 50 through 74 who are at increased risk of severe RSV illness. CDC does not recommend RSV vaccine for every adult 50 and older.

The product names you may hear include Arexvy, mResvia, and Abrysvo. FDA product pages and labels list product-specific indications, which can differ by age and risk group.

For example, FDA lists mResvia for individuals 60 years and older and for individuals 18 through 59 who are at increased risk for RSV lower respiratory tract disease. If you are in the 50 through 59 age range, ask the vaccine provider to match your risk factors with the current CDC recommendation and the current FDA-labeled product options.

For pneumococcal vaccination, you may hear PCV15, PCV20, PCV21, and PPSV23. PCV means pneumococcal conjugate vaccine. PPSV23 is a pneumococcal polysaccharide vaccine. These names matter because the follow-up plan changes by product. If you are comparing records, write down the exact vaccine name and date. A note that only says “pneumonia shot” may not be enough to determine whether another dose is recommended.

Common questions

I am 76 and never had an RSV vaccine. Should I check now? Yes.

Adults 75 and older are in CDC’s recommended adult RSV vaccine group. The best visit timing may depend on the season, your health, and local vaccine availability.

I am 58 with COPD or heart failure. Does RSV vaccine apply to me? Adults 50 through 74 with chronic lung disease or chronic cardiovascular disease are among the groups CDC lists as having increased risk for severe RSV illness.

Review your condition list with the vaccine provider. Is the pneumococcal vaccine only for people 65 and older? No.

CDC recommends pneumococcal vaccination for adults 50 and older who have never received a pneumococcal conjugate vaccine or whose history is unknown. Some younger adults also qualify because of specific risks.

Can I get RSV and pneumococcal vaccines on the same day? Same-visit vaccination may be possible, but the decision should account for which vaccines you are due for, side effect tolerance, and whether splitting visits would make reactions easier to track. What if I already had a pneumonia shot years ago? Find out which product it was.

PCV13, PCV15, PCV20, PCV21, and PPSV23 lead to different next steps. The date and your age at the time also matter.

Do these vaccines prevent every pneumonia or every winter cough? No. RSV vaccine targets RSV-related lower respiratory tract disease.

Pneumococcal vaccines target selected pneumococcal bacteria. Other viruses and bacteria can still cause cough, bronchitis, or pneumonia.

Sources checked

Public-facing official sources checked for this article: